SynthesisClinical and translational science2024

Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review.

Katsutoshi Hiramatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.